Literature DB >> 23632233

Association of obesity with cardiovascular disease mortality in the PLCO trial.

Jieying Jiang1, Jiyoung Ahn, Wen-Yi Huang, Richard B Hayes.   

Abstract

OBJECTIVE: Obesity is a risk factor for cardiovascular disease (CVD) mortality, but the association between obesity and specific causes of CVD mortality is still under investigation.
METHOD: We prospectively examined body-mass index (BMI) in relation to CVD-specific causes of death in approximately 86,000 US men and women in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, followed for up to 13 years. BMI was calculated from self-reported weight and height at baseline. Hazard ratios (HRs) were calculated overall and stratified by sex, smoking status, and educational level. RESULT: Overweight non-obese participants (BMI: 25.0-29.9) were not at excess risk for CVD mortality (HR and CIs are 1.02 [0.92-1.13]), compared to participants of normal BMI (18.5-24.9). Excess CVD mortality was observed for participants of BMI 30.0-34.9 (HR and CIs: 1.29 [1.13-1.48]), BMI 35.0-39.9 (HR and CIs: 1.87 [1.51-2.32]) and BMI 40.0+ (HR and CIs: 2.21 [1.57-3.21]) (p<0.001 for trend). BMI was unrelated to mortality due to stroke. The observed association of BMI with CVD was independent of gender, smoking status and educational level.
CONCLUSION: Obesity is associated with increased mortality due to CVD.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23632233      PMCID: PMC3674167          DOI: 10.1016/j.ypmed.2013.04.014

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  40 in total

Review 1.  Associations between obesity and health conditions may be overestimated if self-reported body mass index is used.

Authors:  A Chiolero; I Peytremann-Bridevaux; F Paccaud
Journal:  Obes Rev       Date:  2007-07       Impact factor: 9.213

2.  Body-mass index and mortality among 1.46 million white adults.

Authors:  Amy Berrington de Gonzalez; Patricia Hartge; James R Cerhan; Alan J Flint; Lindsay Hannan; Robert J MacInnis; Steven C Moore; Geoffrey S Tobias; Hoda Anton-Culver; Laura Beane Freeman; W Lawrence Beeson; Sandra L Clipp; Dallas R English; Aaron R Folsom; D Michal Freedman; Graham Giles; Niclas Hakansson; Katherine D Henderson; Judith Hoffman-Bolton; Jane A Hoppin; Karen L Koenig; I-Min Lee; Martha S Linet; Yikyung Park; Gaia Pocobelli; Arthur Schatzkin; Howard D Sesso; Elisabete Weiderpass; Bradley J Willcox; Alicja Wolk; Anne Zeleniuch-Jacquotte; Walter C Willett; Michael J Thun
Journal:  N Engl J Med       Date:  2010-12-02       Impact factor: 91.245

3.  Measures of adiposity and future risk of ischemic stroke and coronary heart disease in older men and women.

Authors:  Jorge R Kizer; Mary L Biggs; Joachim H Ix; Kenneth J Mukamal; Susan J Zieman; Ian H de Boer; Dariush Mozaffarian; Joshua I Barzilay; Elsa S Strotmeyer; Jose A Luchsinger; Mitchell S V Elkind; W T Longstreth; Lewis H Kuller; David S Siscovick
Journal:  Am J Epidemiol       Date:  2010-12-01       Impact factor: 4.897

4.  Triglyceride concentration and coronary heart disease.

Authors:  A M Garber; A L Avins
Journal:  BMJ       Date:  1994-11-26

5.  A prospective study of body mass index, weight change, and risk of stroke in women.

Authors:  K M Rexrode; C H Hennekens; W C Willett; G A Colditz; M J Stampfer; J W Rich-Edwards; F E Speizer; J E Manson
Journal:  JAMA       Date:  1997-05-21       Impact factor: 56.272

6.  The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.

Authors:  J K Gohagan; P C Prorok; R B Hayes; B S Kramer
Journal:  Control Clin Trials       Date:  2000-12

7.  Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants.

Authors:  C Ni Mhurchu; A Rodgers; W H Pan; D F Gu; M Woodward
Journal:  Int J Epidemiol       Date:  2004-04-22       Impact factor: 7.196

Review 8.  The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review.

Authors:  Matthias Lenz; Tanja Richter; Ingrid Mühlhauser
Journal:  Dtsch Arztebl Int       Date:  2009-10-02       Impact factor: 5.594

9.  Prevention of cardiovascular diseases: Role of exercise, dietary interventions, obesity and smoking cessation.

Authors:  Harpal S Buttar; Timao Li; Nivedita Ravi
Journal:  Exp Clin Cardiol       Date:  2005

10.  Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk?: evidence from an individual-participant meta-analysis of 82 864 participants from nine cohort studies.

Authors:  S Czernichow; A-P Kengne; E Stamatakis; M Hamer; G D Batty
Journal:  Obes Rev       Date:  2011-04-27       Impact factor: 9.213

View more
  20 in total

1.  Life Expectancy and Mortality Rates in the United States, 1959-2017.

Authors:  Steven H Woolf; Heidi Schoomaker
Journal:  JAMA       Date:  2019-11-26       Impact factor: 56.272

2.  22nd European Congress on Obesity (ECO2015), Prague, Czech Republic, May 6-9, 2015: Abstracts.

Authors: 
Journal:  Obes Facts       Date:  2015-04-30       Impact factor: 3.942

3.  Cardiovascular risk profile in Mediterranean patients submitted to bariatric surgery and intensive lifestyle intervention: impact of both interventions after 1 year of follow-up.

Authors:  Pilar Sanchis; Carla Frances; Joana Nicolau; Rosmeri Rivera; Regina Fortuny; Xavier Julian; Salvador Pascual; Luis A Gomez; Irene Rodriguez; Josefina Olivares; Luisa Ayala; Luis Masmiquel
Journal:  Obes Surg       Date:  2015-01       Impact factor: 4.129

4.  Endothelin receptor blockade blunts the pressor response to acute stress in men and women with obesity.

Authors:  Cassandra C Derella; Anson M Blanks; Xiaoling Wang; Matthew A Tucker; Chase Horsager; Jin Hee Jeong; Paula Rodriguez-Miguelez; Jacob Looney; Jeffrey Thomas; David M Pollock; Ryan A Harris
Journal:  J Appl Physiol (1985)       Date:  2021-11-11

5.  Dual endothelin receptor antagonism increases resting energy expenditure in people with increased adiposity.

Authors:  Cassandra C Derella; Anson M Blanks; Andy Nguyen; Jacob Looney; Matthew A Tucker; Jinhee Jeong; Paula Rodriguez-Miguelez; Jeffrey Thomas; Matthew Lyon; David M Pollock; Ryan A Harris
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-04-04       Impact factor: 5.900

6.  Outcomes of a Pilot Intervention Study for Young Adults at Risk for Cardiovascular Disease Based on Their Family History.

Authors:  Christopher C Imes; Cynthia M Dougherty; Frances Marcus Lewis; Melissa A Austin
Journal:  J Cardiovasc Nurs       Date:  2016 Sep-Oct       Impact factor: 2.083

7.  Perceived stress and coping strategies in relation to body mass index: cross-sectional study of 12,045 Japanese men and women.

Authors:  Chisato Shimanoe; Megumi Hara; Yuichiro Nishida; Hinako Nanri; Yasuko Otsuka; Kazuyo Nakamura; Yasuki Higaki; Takeshi Imaizumi; Naoto Taguchi; Tatsuhiko Sakamoto; Mikako Horita; Koichi Shinchi; Keitaro Tanaka
Journal:  PLoS One       Date:  2015-02-12       Impact factor: 3.240

8.  Are Complexity Metrics Reliable in Assessing HRV Control in Obese Patients During Sleep?

Authors:  Ramona Cabiddu; Renata Trimer; Audrey Borghi-Silva; Matteo Migliorini; Renata G Mendes; Antonio D Oliveira; Fernando S M Costa; Anna M Bianchi
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

9.  Predictive power of a body shape index for development of diabetes, hypertension, and dyslipidemia in Japanese adults: a retrospective cohort study.

Authors:  Misuzu Fujita; Yasunori Sato; Kengo Nagashima; Sho Takahashi; Akira Hata
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

10.  Excessive Daytime Sleepiness and Cardiovascular Mortality in US Adults: A NHANES 2005-2008 Follow-Up Study.

Authors:  Jingen Li; Naima Covassin; Joshua M Bock; Essa A Mohamed; Lakshmi P Pappoppula; Chilsia Shafi; Francisco Lopez-Jimenez; Virend K Somers
Journal:  Nat Sci Sleep       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.